L&K Spine proudly announces that its innovative Expandable TLIF/PLIF interbody cage, PathLoc-TM, has now been implanted in over 4,000 spinal levels across the U.S. as of July 17, with zero reported device-related failures—a milestone that underscores the product’s strong clinical track record and growing adoption among U.S. spine surgeons.
The TLIF/PLIF expandable cage, engineered to streamline insertion and optimize anatomical restoration, has rapidly gained traction among U.S. spine surgeons seeking efficiency, control, and long-term reliability.
“This milestone validates what surgeons across the country have experienced firsthand: confidence in every expansion,” said Alex Kang, CEO of L&K Spine. “We designed this implant with precision expandability, intuitive instrumentation, and uncompromised endplate coverage—and the clinical track record proves it delivers.”
Ideal for both minimally invasive and open TLIF/PLIF procedures, the cage enables controlled in situ height restoration and lordotic correction, while reducing insertion force and neural retraction.
Surgeons have cited ease of use, excellent tactile control, and robust postoperative outcomes as key factors driving adoption.
As L&K Spine continues to expand its U.S. footprint, this milestone reinforces its commitment to delivering dependable, high-performance spinal solutions that meet the real-world needs of today’s spine surgeons.
To learn more or request a demo, visit www.lnkbiomed.com or contact marketing@lnkspineinc.com.
About L&K Spine
L&K Spine is a U.S.-based provider of high-performance spinal implant solutions. Focused on delivering clinically trusted innovation, the company partners with leading surgeons to improve surgical outcomes through intelligent design and dependable results.
